Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
US-2025249042-A1 · Aug 7, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ring Aaron Michael patents
Ring Aaron Michael is listed as an inventor on 50 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ring Aaron Michael |
| Total patents | 50 |
| First publication | Mar 12, 2015 |
| Latest publication | Aug 7, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
High affinity sirp-alpha reagents and methods of using
US-2025223355-A1 · Jul 10, 2025 · US
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
US-12233093-B2 · Feb 25, 2025 · US
High affinity SIRP-alpha reagents and methods of using
US-12195532-B2 · Jan 14, 2025 · US
High affinity pd-1 agents and methods of use
US-2024174729-A1 · May 30, 2024 · US
High affinity PD-1 agents and methods of use
US-11814419-B2 · Nov 14, 2023 · US
Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPalpha antibody therapy
US-11718675-B2 · Aug 8, 2023 · US
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
US-2022347224-A1 · Nov 3, 2022 · US
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
US-11459388-B2 · Oct 4, 2022 · US
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
US-11419897-B2 · Aug 23, 2022 · US
Recent patents
Latest publications not already listed above.
High affinity sirp-alpha reagents and methods of using
US-2022064293-A1 · Mar 3, 2022 · US
High affinity SIRP-alpha reagents and methods of using
US-11208481-B2 · Dec 28, 2021 · US
Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulator
US-11041868-B2 · Jun 22, 2021 · US
Compositions and methods for inducing phagocytosis of mhc class i positive cells and countering anti-cd47/sirpa resistance
US-2021101985-A1 · Apr 8, 2021 · US
Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells
US-10934331-B2 · Mar 2, 2021 · US
High affinity pd-1 agents and methods of use
US-2021040176-A1 · Feb 11, 2021 · US
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
US-10889649-B2 · Jan 12, 2021 · US
Compositions and methods for expressing polypeptides on the surface of cells
US-10829771-B2 · Nov 10, 2020 · US
High affinity PD-1 agents and methods of use
US-10800830-B2 · Oct 13, 2020 · US
Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies
US-10781256-B2 · Sep 22, 2020 · US
Disrupting FC Receptor Engagement on Macrophages Enhances Efficacy of Anti-SIRPalpha Antibody Therapy
US-2020262918-A1 · Aug 20, 2020 · US
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
US-2020129557-A1 · Apr 30, 2020 · US
SIRP-α agonist antibody
US-10618976-B2 · Apr 14, 2020 · US
Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapy
US-10611842-B2 · Apr 7, 2020 · US
Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective manner
US-10520516-B2 · Dec 31, 2019 · US
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
US-10406179-B2 · Sep 10, 2019 · US
Compositions and methods for inducing phagocytosis of mhc class i positive cells and countering anti-cd47/sirpa resistance
US-2019241664-A1 · Aug 8, 2019 · US
High affinity CD47 analogs
US-10358472-B2 · Jul 23, 2019 · US
Compositions and methods for enhancing immunogenic cross-presentation of tumor antigens
US-2019218260-A1 · Jul 18, 2019 · US
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
US-10316094-B2 · Jun 11, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Leland Stanford Junior | 50 |
| Forty Seven Inc | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/2803 | 29 |
| A61P35/00 | 25 |
| A61K45/06 | 23 |
| A61K38/1774 | 21 |
| C07K2319/30 | 20 |